In April 2021, we reached a strategic cooperation with Shanghai Asclepius Meditec and officially launched the hydrogen oxygen medical project; at the same time, we strategically invested in Asclepius Meditec and became its national agent for hydrogen oxygen products, both sides will give full play to their resource advantages and empower both sides to create an example of close integration between innovative medical products and medical instrument supply chain channels, and we will help Shanghai Asclepius Meditec to complete channel construction and sales through free e-commerce platform + terminal Medical device stores quickly focus resources to help Shanghai Asclepius Meditec to complete channel construction and sales, accelerate the layout of the national medical device channel, and build a full-scene channel solution!

Introduction of hydrogen oxygen machine

Chemical reduction：After entering cells, it binds to malignant free radicals (·OH, ONOO-), providing safe and effective anti-inflammatory and antioxidant pathways to relieve inflammation, and can enhance the ability of mitochondria to produce cellular energy ATP.

Physical effects：Using hydrogen 10-10 tiny molecules to help oxygen dispersion, improve the state of low blood oxygen, the original water shock nebulization function, to help the liquid small molecules into the cells easily absorbed, enhance the effectiveness of drugs.

From the global patent technology check verification, its safety design, zero air cavity, multiple explosion-proof, multi-layer filter bacteria, long operation, concentration wise control, twenty-four physiological indicators detection of the wearable bracelet with the advantages, in line with the small size, gas production, human safety, good therapeutic effect of respiratory therapy equipment.

In March 2017, the Asclepius Miditec hydrogen oxygen nebulizer was approved to enter the green channel of "National Innovation" Class III medical device.

February 2020 Asclepius Miditec hydrogen oxygen nebulizer obtained the registration certificate of Class III medical device of the People's Republic of China

Legal clinical application devices included in the seventh edition of the national treatment protocol for COVID 19 in March 2020